Michael Tintiuc

Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development.

WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada.

Teijin Pharma Ltd. engages in the development, production, sales, and marketing of pharmaceuticals, and medical devices and supplies. The company operates in pharmaceutical and home healthcare businesses, focusing on bone and joint diseases, respiratory diseases, and cardiovascular and metabolic diseases. The company was founded in 2002 and is headquartered in Tokyo, Japan.

Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada.

Shogoo Pharmaceuticals KK provides novel pharmaceutical products. It also licenses, develops, imports, exports, markets, and distributes pharmaceutical products. It provides medicines mainly for high unmet diseases. Shogoo Pharmaceuticals was founded in 2005 and is located in Tokyo, Japan.